ArticleAmerican health & drug benefits2017

Comparing Medication Adherence and Persistence Among Patients with Type 2 Diabetes Using Sodium-Glucose Cotransporter 2 Inhibitors or Sulfonylureas.

Kelly F Bell et al.PubMed ↗Full text ↗

No numbers read from the abstract.